453 views
mRNA vaccines have been known since the COVID19 pandemic at the latest. They could soon be approved in this country for the treatment of skin tumors. But can cancer simply be injected away? Science journalist Jens Schröder talks to dermatologist Christoffer Gebhardt about the latest findings in cancer research. Skin cancer is the most common form of cancer in the world and the number of new cases is increasing dramatically. Black skin cancer, also known as malignant melanoma, is considered particularly dangerous because it can spread quickly in the body. However, a new therapeutic approach is on the rise for advanced black skin cancer. mRNA vaccines, which have already been used successfully in the fight against the corona pandemic, are currently being tested as immunotherapy against skin cancer. These vaccines are to be individually tailored to the specific characteristics of a melanoma. This means that they could be used to tailor them to each patient. The cancer vaccine supports the immune system in recognizing and specifically attacking degenerated cells. But how exactly do these vaccines work and what challenges are researchers currently facing? Dermatologist Christoffer Gebhardt talks to science podcaster Jens Schröder about the promising therapeutic approach in the fight against malignant melanoma. #research #society #innovation